Medline - Class A (MDLN) closed at $39.98 on November 12, 2026, down 5.2% from the previous close, on volume of 8,314,048 shares (30-day average 9,411,604).
Data as of November 12, 2026.
12-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Strangle or Risk Reversal | 20-Nov-2630 P : 37.5 C | 6,740 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Fri, 13-Nov 7:30 AM ET)
RBC Capital Keeps Their Buy Rating on Medline (MDLN)
TipRanks (Wed, 11-Nov 10:06 AM ET)
Globe Newswire (Wed, 11-Nov 6:03 AM ET)
Analysts Offer Insights on NA Companies: Micron (MU), Medline (MDLN) and Ralliant Corporation (RAL)
TipRanks (Mon, 9-Nov 1:30 PM ET)
Medline Earnings Call: Growth Meets Margin Pressure
TipRanks (Sun, 8-Nov 7:07 PM ET)
Market Chameleon (Wed, 4-Nov 3:24 AM ET)
Medline Reports Third Quarter and Nine Months 2026 Results
Globe Newswire (Wed, 4-Nov 7:30 AM ET)
Globe Newswire (Wed, 4-Nov 6:18 AM ET)
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
Globe Newswire (Mon, 2-Nov 4:15 PM ET)
Globe Newswire (Fri, 30-Oct 6:18 AM ET)
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.
As of November 12, 2026, MDLN stock price declined to $39.98 with 8,314,048 million shares trading.
MDLN has a beta of 0.39, meaning it tends to be less sensitive to market movements. MDLN has a correlation of 0.01 to the broad based SPY ETF.
MDLN has a market cap of $35.13 billion. This is considered a Large Cap stock.
Last quarter Medline - Class A reported $8 billion in Revenue and $.44 earnings per share. This beat revenue expectation by $141 million and exceeded earnings estimates by $.10.
The top ETF exchange traded funds that MDLN belongs to (by Net Assets): VTI, VO, VXF, VTV, VOE.
MDLN support price is $41.08 and resistance is $43.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.
